Update on Tutivia™ test adoption

AI SummaryClose X

Verici Dx PLC reported progress in Tutivia test adoption following their July equity fundraise. In Q3, the company saw a 19% increase in ordering clinicians and added nine new transplant centers, bringing the total to 30 onboarded centers. These centers represent 16% of annual transplants in the US. The company also expanded its commercial team with three new senior sales hires and will add a Director of Clinical Partnerships in mid-October. The number of orders in Q3 were consistent with the previous two quarters, and volume growth from recent progress is expected from Q4. The Board continues to target meeting market expectations for the full year.

Disclaimer*

Companies

Verici DX (VRCI)
UK 100

Latest directors dealings